| RS121908575 |
BCS1L
|
Health Risk |
Likely pathogenic |
Mitochondrial complex III deficiency nuclear type 1, Pili torti-deafness syndrome |
| RS121908576 |
BCS1L
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 1, BCS1L-related disorder |
| RS121908577 |
BCS1L
|
Health Risk |
Pathogenic |
Pili torti-deafness syndrome, Leigh syndrome |
| RS121908578 |
BCS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY, Mitochondrial complex III deficiency nuclear type 1 |
| RS121908579 |
BCS1L
|
Health Risk |
Pathogenic |
BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY, BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY |
| RS121908580 |
BCS1L
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 1, Mitochondrial complex III deficiency nuclear type 1 |
| RS121908581 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome |
| RS121908582 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS121908583 |
DPM1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation type 1E, DPM1-related disorder |
| RS121908584 |
GLRX5
|
Health Risk |
Pathogenic |
Sideroblastic anemia 3, Sideroblastic anemia 3 |
| RS121908585 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Primary intracranial sarcoma |
| RS121908586 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Polyps |
| RS121908588 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyps, multiple and recurrent inflammatory fibroid |
| RS121908589 |
PDGFRA
|
Health Risk |
Pathogenic |
Polyps, multiple and recurrent inflammatory fibroid |
| RS121908590 |
KCNA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS121908592 |
KCNA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial fibrillation, familial |
| RS121908593 |
KCNA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS121908594 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 3, Cardio-facio-cutaneous syndrome |
| RS121908595 |
MAP2K1
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 3, Cardio-facio-cutaneous syndrome |
| RS121908596 |
MAP2K1
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 3, Cardio-facio-cutaneous syndrome |
| RS121908598 |
OTOF
|
Health Risk |
Pathogenic |
Auditory neuropathy, autosomal recessive |
| RS121908602 |
ZFPM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Diaphragmatic hernia 3, Diaphragmatic hernia 3 |
| RS121908603 |
ZFPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Diaphragmatic hernia 3, Double outlet right ventricle |
| RS121908604 |
ZFPM2
|
Health Risk |
Pathogenic |
Diaphragmatic hernia 3, Diaphragmatic hernia 3 |
| RS121908605 |
MOCS2
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS121908606 |
MOCS2
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS121908607 |
MOCS2
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS121908608 |
MOCS2
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS121908609 |
MOCS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS121908610 |
CYP7B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 5A, Hereditary spastic paraplegia |
| RS121908611 |
CYP7B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 5A, Spastic paraplegia |
| RS121908612 |
CYP7B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 5A, Hereditary spastic paraplegia 5A |
| RS121908613 |
CYP7B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 5A, Hereditary spastic paraplegia |
| RS121908614 |
CYP7B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 5A, Spastic paraplegia |
| RS121908616 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS121908617 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS121908618 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS121908619 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS121908620 |
CHST3
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS121908621 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, Inborn genetic diseases |
| RS121908622 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS121908623 |
GNE
|
Health Risk |
Likely pathogenic |
Sialuria, Sialuria |
| RS121908625 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS121908626 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS121908627 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS121908628 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, GNE myopathy |
| RS121908629 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS121908630 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS121908632 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS121908633 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, GNE myopathy |
| RS121908634 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, GNE myopathy |
| RS121908635 |
PER2
|
Health Risk |
Pathogenic |
Advanced sleep phase syndrome 1, Advanced sleep phase syndrome 1 |
| RS121908636 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908637 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS121908638 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908639 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908640 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS121908641 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908642 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908643 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908644 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908645 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908646 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, mild |
| RS121908647 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, mild |
| RS121908648 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS121908649 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia 1 |
| RS121908650 |
WNT4
|
Health Risk |
Pathogenic |
Mullerian aplasia and hyperandrogenism, Mullerian aplasia and hyperandrogenism |
| RS121908651 |
WNT4
|
Health Risk |
Pathogenic |
SERKAL syndrome, SERKAL syndrome |
| RS121908652 |
WNT4
|
Health Risk |
Pathogenic |
Mullerian aplasia and hyperandrogenism, Mullerian aplasia and hyperandrogenism |
| RS121908653 |
WNT4
|
Health Risk |
Pathogenic |
Mullerian aplasia and hyperandrogenism, Mullerian aplasia and hyperandrogenism |
| RS121908654 |
AURKC
|
Health Risk |
Pathogenic |
Infertility associated with multi-tailed spermatozoa and excessive DNA, Infertility associated with multi-tailed spermatozoa and excessive DNA |
| RS121908655 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS121908656 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS121908658 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS121908659 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS121908660 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS121908661 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, 8 conditions |
| RS121908662 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS121908663 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS121908664 |
LRP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteoporosis with pseudoglioma, Exudative vitreoretinopathy 1 |
| RS121908665 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteoporosis with pseudoglioma, Osteogenesis imperfecta |
| RS121908666 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS121908667 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS121908668 |
LRP5
|
Health Risk |
Likely pathogenic |
High bone mass, Disorder of bone |
| RS121908669 |
LRP5
|
Health Risk |
Pathogenic |
Autosomal dominant osteopetrosis 1, Autosomal dominant osteopetrosis 1 |
| RS121908670 |
LRP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant osteopetrosis 1, Worth disease |
| RS121908671 |
LRP5
|
Health Risk |
Pathogenic |
Worth disease, Autosomal dominant osteopetrosis 1 |
| RS121908672 |
LRP5
|
Health Risk |
Pathogenic |
Worth disease, Worth disease |
| RS121908673 |
LRP5
|
Health Risk |
Pathogenic |
Autosomal dominant osteopetrosis 1, Autosomal dominant osteopetrosis 1 |
| RS121908674 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Exudative vitreoretinopathy 4, autosomal recessive |
| RS121908675 |
LARGE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy type B6, LARGE1-Related Disorders |
| RS121908676 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS121908678 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS121908679 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Autoinflammatory syndrome |
| RS121908680 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, Iron accumulation in brain |
| RS121908681 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 2B, Congenital cerebellar hypoplasia |
| RS121908682 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration |
| RS121908683 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Karak syndrome, Neurodegeneration with brain iron accumulation |
| RS121908685 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 2B, Infantile neuroaxonal dystrophy |
| RS121908686 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy |